dipeptidyl
peptidas
type
ii
transmembran
ectopeptidas
receptor
middl
eastern
respiratori
syndrom
coronaviru
merscov
mer
emerg
high
mortal
associ
sever
lung
diseas
lack
autopsi
studi
mer
fatal
hinder
understand
merscov
pathogenesi
investig
spatial
cellular
local
evalu
associ
mer
clinic
diseas
rare
detect
surfac
epithelium
nasal
caviti
conduct
airway
slightli
increas
incid
distal
airway
also
found
subset
mononuclear
leukocyt
serou
cell
submucos
gland
parenchyma
found
princip
type
ii
cell
alveolar
macrophag
also
detect
vascular
endothelium
eg
lymphat
pleural
mesothelia
patient
chronic
lung
diseas
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
exhibit
increas
immunostain
alveolar
epithelia
type
ii
cell
alveolar
macrophag
similar
trend
reactiv
mesothelia
find
suggest
preexist
pulmonari
diseas
could
increas
merscov
receptor
abund
predispos
individu
mer
morbid
mortal
consist
current
clinic
observ
specul
preferenti
spatial
local
alveolar
region
may
explain
mer
character
lower
respiratori
tract
diseas
j
pathol
http
dx
dipeptidyl
peptidas
type
ii
transmembran
ectopeptidas
receptor
middl
eastern
respiratori
syndrom
coronaviru
merscov
mer
emerg
high
mortal
associ
sever
lung
diseas
lack
autopsi
studi
mer
fatal
hinder
understand
merscov
pathogenesi
investig
spatial
cellular
local
evalu
associ
mer
clinic
diseas
rare
detect
surfac
epithelium
nasal
caviti
conduct
airway
slightli
increas
incid
distal
airway
also
found
subset
mononuclear
leukocyt
serou
cell
submucos
gland
parenchyma
found
princip
type
ii
cell
alveolar
macrophag
also
detect
vascular
endothelium
eg
lymphat
pleural
mesothelia
patient
chronic
lung
diseas
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
exhibit
increas
immunostain
alveolar
epithelia
type
ii
cell
alveolar
macrophag
similar
trend
reactiv
mesothelia
find
suggest
preexist
pulmonari
diseas
could
increas
merscov
receptor
abund
predispos
individu
mer
morbid
mortal
consist
current
clinic
observ
specul
preferenti
spatial
local
alveolar
region
may
explain
mer
character
lower
respiratori
tract
diseas
middl
east
respiratori
syndrom
mer
recogn
signific
ill
saudi
arabian
peninsula
caus
agent
rapidli
identifi
novel
coronaviru
cov
dmerscov
sinc
emerg
world
health
organ
notifi
laboratoryconfirm
case
merscov
infect
dozen
countri
result
least
relat
death
http
wwwwhointemergenciesmerscoven
last
access
septemb
avail
data
indic
men
commonli
infect
women
median
age
year
although
humantohuman
zoonot
spread
mer
reach
epidem
pandem
level
potenti
spread
among
individu
found
health
care
set
middl
east
recent
outbreak
south
korea
caus
singl
infect
individu
fatal
mer
case
occur
individu
year
older
frequent
associ
signific
comorbid
obes
renal
cardiac
diseas
diabet
lung
diseas
immunocompromis
sever
affect
individu
manifest
signific
respiratori
symptom
includ
cough
fever
dyspnea
chest
pain
mani
serious
ill
patient
progress
respiratori
failur
requir
ventilatori
support
patient
exhibit
dens
airspac
interstiti
lesion
chest
radiographi
comput
tomographi
addit
pulmonari
manifest
report
problem
serious
ill
patient
includ
hyperkalemia
dissemin
intravascular
coagulopathi
pericardi
effus
central
nervou
system
manifest
multiorgan
failur
date
lack
autopsi
patholog
data
patient
die
mer
hinder
understand
diseas
pathogenesi
epidemiolog
studi
establish
mer
zoonot
origin
evid
close
relat
viru
dromedari
camel
arabian
peninsula
throughout
africa
spread
camel
human
document
well
persontoperson
spread
among
health
care
worker
hospit
set
unlik
super
spreader
case
describ
sarscov
spread
merscov
persontoperson
ineffici
could
chang
viru
evolut
merscov
also
detect
individu
mild
influenzalik
ill
denguelik
ill
without
obviou
diseas
sign
symptom
suggest
may
larger
diseas
burden
current
recogn
shortli
merscov
discov
cellular
receptor
dipeptidyl
peptidas
identifi
structur
residu
compris
receptorbind
domain
defin
cocrystal
merscov
spike
glycoprotein
singlepass
type
ii
transmembran
glycoprotein
short
ntermin
cytoplasm
tail
nativ
protein
homodim
cleav
xprolin
dipeptid
nterminu
polypeptid
may
function
modifi
mani
substrat
includ
growth
factor
neuropeptid
cytokin
chemokin
vasoact
peptid
express
mani
tissu
cell
type
includ
kidney
intestin
liver
thymocyt
sever
cell
hematopoiet
lineag
express
increas
activ
b
natur
killer
cell
consid
marker
function
activ
also
shed
surfac
mani
cell
type
present
solubl
form
plasma
although
limit
report
describ
aspect
express
anim
human
tissu
cell
type
comprehens
survey
cellular
express
human
respiratori
tract
local
express
normal
diseas
human
respiratori
tissu
identifi
pulmonari
cell
type
may
suscept
merscov
infect
therebi
obtain
insight
mer
pathogenesi
studi
approv
institut
review
board
univers
iowa
formalinfix
paraffinembed
ffpe
lung
tissu
collect
archiv
tissu
autopsi
tissu
lung
donor
wherea
archiv
nasal
tissu
n
z
collect
biopsi
sampl
portion
case
also
trachea
primari
bronchi
larg
airway
avail
examin
score
immunostain
compar
small
airway
defin
intrapulmonari
bronchi
bronchiol
tabl
gather
suffici
lung
sampl
compar
clinic
group
tabl
group
compos
healthi
lung
tissu
defin
lack
clinic
evid
activ
chronic
lung
diseas
wherea
group
compos
chronic
lung
diseas
tissu
defin
chronic
obstruct
pulmonari
diseas
copd
n
z
cystic
fibrosi
cf
n
z
clinic
diagnos
use
control
popul
group
even
though
healthi
often
younger
allow
sever
advantag
provid
control
group
comparison
diseas
individu
group
furthermor
total
pool
case
rang
month
year
age
allow
evalu
agerel
chang
express
tabl
express
detect
use
immunohistochemistri
ihc
paraffinembed
tissu
briefli
tissu
section
approxim
mm
hydrat
seri
grade
alcohol
xylen
bath
antigen
mannwhitney
utest
compar
group
unaffect
group
copd
cf
bold
text
indic
p
cf
cystic
fibrosi
copd
chronic
obstruct
pulmonari
diseas
smg
submucos
gland
american
journal
pathologyajpamjpatholorg
retriev
perform
decloak
chamber
nxgen
biocar
medic
concord
ca
citrat
buffer
ph
c
minut
endogen
peroxidas
quench
hydrogen
peroxid
minut
nonspecif
background
block
hors
serum
minut
detect
use
mous
monoclon
antibodi
clone
origen
technolog
inc
rockvil
md
secondari
kit
mouseonfarma
biocar
medic
antibodi
visual
chromogen
dab
plu
dab
enhanc
dako
carpinteria
ca
slide
dehydr
seri
alcohol
xylen
bath
routin
coverslip
immunostain
optim
valid
ffpe
primari
airway
cell
cultur
either
express
lack
express
addit
valid
step
perform
human
kidney
renal
tubul
known
robust
immunostain
step
use
enhanc
specif
stain
greatli
minim
nonspecif
stain
confound
local
studi
tissu
furthermor
optim
valid
studi
perform
ffpe
tissu
similar
test
sampl
enhanc
consist
tissu
evalu
score
pathologist
use
postexamin
mask
techniqu
express
lung
assess
score
cellular
distribut
immunostain
accord
morpholog
cell
type
use
follow
grade
absent
rare
low
number
moder
number
common
evalu
express
chang
within
lung
area
without
diseas
eg
hyperplasia
inflamm
remodel
select
case
cf
alveolar
macrophag
select
studi
easili
identifi
singl
cell
within
alveolar
lumen
wherea
cell
type
difficult
definit
discern
absenc
stain
could
skew
result
alveolar
macrophag
per
sampl
area
count
score
stain
use
follow
grade
stain
weak
percept
stain
moder
diffus
cytoplasm
stain
robust
dark
stain
score
averag
area
without
diseas
compar
use
pair
ttest
unless
otherwis
specifi
comparison
morphometr
score
data
group
perform
mannwhitney
test
statist
signific
set
p
determin
cellular
express
protein
human
respiratori
tract
nasal
caviti
airway
lung
surfac
epithelium
nasal
mucosa
lack
immunostain
figur
contrast
immunostain
seen
scatter
mononuclear
lymphoid
cell
apic
surfac
serou
cell
submucos
gland
cell
figur
b
surfac
epithelium
immunostain
detect
uncommon
foci
solitari
scatter
goblet
cell
noncili
cell
andor
ciliat
cell
figur
also
detect
scatter
mononuclear
round
cell
within
epithelium
subepitheli
tissu
figur
cee
robust
apic
cytoplasm
immunostain
present
submucos
gland
serou
cell
rare
duct
epitheli
cell
lack
mucou
cell
figur
b
c
sometim
signal
appear
fill
lumin
space
figur
possibl
repres
solubl
releas
serou
cell
ductal
epithelia
combin
thereof
also
occasion
observ
cytoplasm
stain
noncili
cell
appear
undergo
morpholog
degener
extrus
surfac
epithelium
figur
although
cell
stain
uncommon
conduct
airway
smaller
airway
appear
frequent
detect
surfac
epithelia
test
examin
immunostain
score
larg
airway
compar
small
airway
smaller
airway
nonsignific
trend
toward
increas
incid
immunostain
ciliat
noncili
cell
tabl
observ
may
also
influenc
larger
sampl
area
repres
smaller
airway
compar
larger
airway
microscop
lung
section
immunostain
detect
alveolar
type
ii
cell
type
cell
alveolar
macrophag
figur
endothelium
pulmonari
vessel
multifoc
immunostain
figur
thin
wall
vessel
devoid
erythrocyt
indic
lymphat
figur
often
stronger
stain
erythrocyt
indic
venul
gener
gradient
stain
intens
observ
lymphat
greater
venul
greater
arteriol
capillari
occasion
stain
interest
intravascular
valv
present
figur
exhibit
preferenti
strong
stain
lymphat
vein
pulmonari
lymph
node
also
abund
immunostain
lymphat
vessel
medullari
sinus
figur
american
journal
pathologyajpamjpatholorg
mesotheli
line
cell
viscer
pleura
often
immunostain
except
section
lung
appar
dryingslough
artifact
occur
tissu
prepar
figur
area
remodel
hypertrophi
mesotheli
cell
often
correspond
increas
immunostain
compar
unreact
pleura
lung
figur
c
alveolar
macrophag
often
similarli
weak
moder
immunostain
lung
figur
howev
lung
immunostain
promin
activ
alveolar
macrophag
near
site
diseas
eg
remodel
figur
c
chang
corrobor
semiquantit
score
figur
compar
score
group
healthi
group
chronic
diseas
determin
whether
chronic
lung
diseas
affect
express
tabl
score
immunostain
type
type
ii
figur
b
cell
significantli
increas
group
lung
tabl
alveolar
macrophag
also
similar
signific
increas
stain
group
neutrophil
group
consist
lack
figur
addit
observ
group
differ
mean
age
tabl
could
possibl
contribut
increas
score
type
type
ii
cell
address
examin
signific
paramet
tabl
determin
whether
correl
score
progress
age
tabl
although
signific
correl
score
type
cell
increas
age
type
ii
cell
neg
correl
group
r
z
p
z
lack
signific
correl
group
combin
tabl
find
suggest
increas
score
age
relat
like
respons
chronic
lung
diseas
addit
question
interest
whether
femal
male
sex
contribut
chang
express
detect
signific
sexspecif
chang
express
alveolar
type
ii
cell
alveolar
macrophag
figur
e
evalu
express
respiratori
tract
better
understand
associ
potenti
pathogenesi
clinic
diseas
merscov
infect
known
patient
mer
develop
sever
respiratori
diseas
groundglass
chang
edema
pleural
effus
chest
comput
tomographi
typifi
lung
lesion
howev
detail
descript
merscov
lung
diseas
remain
elus
absenc
autopsi
case
diagnost
evalu
result
provid
first
comprehens
local
merscov
receptor
human
lung
tissu
scatter
cell
surfac
epithelia
express
nasal
caviti
conduct
airway
find
nomin
express
conduct
airway
consist
report
van
der
velden
et
al
investig
express
human
bronchu
healthi
individu
asthmat
patient
note
local
surfac
epithelia
robust
express
submucos
gland
epithelia
detect
express
cell
within
lung
parenchyma
eg
type
ii
cell
interstitium
endotheli
cell
leukocyt
macrophag
mononuclear
lymphoid
cell
find
might
suggest
merscov
exposur
airway
epithelia
remodel
semiquantit
score
use
compar
group
healthi
group
diseas
tissu
data
express
mean
ae
sd
p
pair
ttest
ajpamjpatholorg
american
journal
patholog
could
provid
nomin
preliminari
conduit
infect
primari
site
infect
concept
consist
lack
evid
airway
centric
diseas
human
anim
model
may
explain
poor
transmiss
merscov
contrast
submucos
gland
exhibit
robust
express
serou
epitheli
cell
submucos
gland
lumen
like
repres
solubl
secret
solubl
present
bronchoalveolar
lavag
fluid
level
regul
independ
serum
level
extracellular
domain
cleav
sheddas
matrix
metalloproteinas
mmp
solubl
also
detect
pleural
fluid
inflammatori
lung
condit
smoke
bronchoalveolar
lavag
level
solubl
reduc
wherea
set
asthma
unchang
increas
submucos
gland
secret
normal
bath
airway
surfac
thu
solubl
submucos
gland
surfac
epithelia
may
bind
merscov
spike
protein
specul
competit
inhibit
viru
bind
report
vitro
contrast
conduct
airway
lung
parenchyma
interstitium
rel
rich
cellular
sourc
protein
merscov
infect
pulmonari
cell
type
would
like
contribut
consist
report
parenchym
lesion
observ
lung
imag
diffus
alveolar
damag
hypothes
diseas
state
might
modifi
express
interest
express
cell
eg
mesothelium
macrophag
increas
site
heterogen
remodel
compar
healthi
site
lung
find
along
signific
enhanc
express
score
type
type
ii
cell
tabl
interest
consid
express
immun
cell
vascular
endothelia
might
contribut
merscoverel
diseas
macrophag
plasmacytoid
dendrit
cell
express
suscept
merscov
entri
monocytederiv
macrophag
support
product
merscov
infect
wherea
plasmacytoid
dendrit
cell
support
viru
entri
releas
cytokin
interferon
respons
entri
allow
viru
complet
replic
cycl
chu
et
al
report
human
lymphocyt
peripher
blood
lymphoid
organ
infect
merscov
interest
merscov
infect
lymphocyt
activ
extrins
intrins
apoptosi
pathway
addit
alveolar
macrophag
mononuclear
cell
found
signific
immunostain
endothelia
lymphat
vasculatur
cell
type
structur
becom
infect
possibl
could
contribut
mer
diseas
pathogenesi
facilit
spread
organ
catalyt
domain
function
cleav
xprolin
dipeptid
nterminu
polypeptid
cellassoci
solubl
regul
function
activ
bioactiv
peptid
includ
neuropeptid
vasoact
peptid
cytokin
chemokin
remov
ntermin
amino
acid
present
studi
publish
result
indic
could
modifi
peptid
function
mani
site
includ
airway
alveolar
epithelia
bronchoalveolar
lavag
endothelia
includ
lymphat
immun
cell
mesothelia
exampl
known
substrat
includ
sever
chemokin
catalyt
action
substrat
chemokin
usual
reduc
ligand
agonist
properti
exampl
cleavag
yield
domin
neg
antagonist
peptid
product
current
known
whether
sever
infect
mer
alter
abund
function
respiratori
tract
could
possibl
influenc
kinet
inflamm
enter
lung
addit
recent
evid
may
act
proinflammatori
signal
molecul
chan
et
al
found
merscov
product
replic
human
bronchial
lung
tissu
grown
ex
vivo
organ
cultur
report
viru
infect
noncili
bronchial
epithelium
bronchiolar
epitheli
cell
alveolar
epitheli
cell
endotheli
cell
hock
et
al
also
use
ex
vivo
organ
cultur
human
lung
studi
merscov
cell
tropism
observ
merscov
infect
cell
type
alveolar
compart
detect
morpholog
correl
sever
lung
injuri
although
ex
vivo
model
use
possibl
cultur
condit
may
alter
nativ
express
factor
influenc
cell
suscept
merscov
infect
sever
group
report
infect
airway
epitheli
cell
line
merscov
elicit
rang
transcript
protein
respons
includ
antagon
interferon
respons
induct
pathway
gene
differenti
express
cytokin
chemokin
current
known
infect
endothelia
mesothelia
immun
cell
type
merscov
might
influenc
diseas
outcom
studi
advantag
limit
one
advantag
use
cell
cultur
known
posit
tissu
optim
valid
techniqu
maxim
specif
minim
nonspecif
background
easili
confound
local
studi
anoth
advantag
immunostain
tissu
rang
healthi
diseas
individu
comprehens
investig
distribut
across
lung
cell
type
studi
use
activityebas
local
techniqu
addit
immunoloc
vitro
cultur
primari
cell
cell
line
note
found
tissu
patient
copd
cf
exhibit
area
enhanc
immunostain
airway
epithelia
type
ii
epithelia
pleural
mesothelia
alveolar
macrophag
disadvantag
studi
tissu
diseas
state
tend
older
individu
age
differ
appear
directli
influenc
studi
find
anoth
limit
studi
rel
small
number
case
copd
cf
group
even
identifi
signific
trend
cohort
furthermor
small
sampl
size
nasal
tissu
biopsi
constrain
tissu
area
examin
compar
tissu
small
sampl
could
explain
absenc
stain
nasal
surfac
epithelium
compar
spars
stain
airway
surfac
epithelium
acknowledg
littl
express
may
requir
confer
suscept
merscov
infect
could
level
detect
optim
ihc
techniqu
also
specul
although
express
alon
suffici
confer
suscept
merscov
infect
resist
cell
possibl
may
current
unknown
celltyp
specif
cofactor
host
proteas
influenc
diseas
could
evalu
summari
evid
promin
local
parenchym
tissu
may
help
explain
mer
character
lower
respiratori
tract
diseas
ajpamjpatholorg
american
journal
patholog
